{"id":1338,"date":"2017-09-15T21:49:19","date_gmt":"2017-09-15T18:49:19","guid":{"rendered":"https:\/\/tonyaasm.com\/?p=1338"},"modified":"2017-09-15T21:49:19","modified_gmt":"2017-09-15T18:49:19","slug":"15-eylul-dunya-prostat-kanseri-gunu","status":"publish","type":"post","link":"https:\/\/tonyaasm.com\/saglik\/2017\/09\/15-eylul-dunya-prostat-kanseri-gunu\/","title":{"rendered":"15 Eyl\u00fcl D\u00fcnya Prostat Kanseri G\u00fcn\u00fc"},"content":{"rendered":"

\u201cSA\u011eLI\u011eINIZI \u00d6NEMSEY\u0130N, DOKTORUNUZA BA\u015eVURUN\u201d<\/strong><\/p>\n

Prostat kanseri erkeklerde en s\u0131k g\u00f6r\u00fclen i\u00e7 organ kanseri ve t\u00fcm d\u00fcnyada en s\u0131k g\u00f6r\u00fclen ikinci kanser t\u00fcr\u00fcd\u00fcr. Yakla\u015f\u0131k olarak her 6 erkekten birinin prostat kanserine yakalanaca\u011f\u0131 ve her 38 erkekten birinin bu hastal\u0131k nedeniyle hayat\u0131n\u0131 kaybedece\u011fi tahmin edilmektedir. T\u00fcm d\u00fcnyada her y\u0131l 899.000 yeni prostat kanseri saptanmakta ve t\u00fcm d\u00fcnyada 258.000 ki\u015fi prostat kanseri nedeniyle hayat\u0131n\u0131 kaybetmektedir. 2030\u2019lu y\u0131llara gelindi\u011finde ise d\u00fcnyada y\u0131lda 1.700.000 yeni prostat kanseri vakas\u0131 g\u00f6r\u00fclece\u011fi ve 499.000 hastan\u0131n prostat kanseri nedeniyle hayat\u0131n\u0131 kaybedece\u011fi \u00f6ng\u00f6r\u00fclmektedir.<\/p>\n

Prostat kanseri \u00fclkemizde erkeklerde en s\u0131k g\u00f6r\u00fclen ikinci kanser t\u00fcr\u00fcd\u00fcr ve her y\u0131l T\u00fcrkiye de 100.000 erke\u011fin 39\u2019unda bu kanser te\u015fhis edilmektedir. G\u00fcn\u00fcm\u00fczde en \u00f6nemli riskli grubu aile \u00f6yk\u00fcs\u00fc olan bireyler olu\u015fturmakta olup, bu vatanda\u015flar\u0131m\u0131z\u0131n d\u00fczenli olarak \u00fcrolojik muayeneden ge\u00e7mesini \u00f6nermekteyiz.<\/p>\n

Risk Fakt\u00f6rleri: Prostat kanserinin sebepleri kesin olarak bilinmemektedir.<\/strong><\/p>\n

Ya\u015f:<\/strong> Prostat kanserinin en \u00f6nemli risk fakt\u00f6r\u00fcd\u00fcr. 45 ya\u015f alt\u0131nda nadir g\u00f6r\u00fcl\u00fcr. Ya\u015fland\u0131k\u00e7a risk artar.
\nAile \u00f6yk\u00fcs\u00fc:<\/strong> 1.derece akrabalar\u0131nda prostat kanseri olanlarda risk artar.
\nBelirli prostat de\u011fi\u015fiklikleri: Y\u00fcksek dereceli prostatik intraepitelyal neoplazisi olan h\u00fccreleri olanlarda prostat kanseri riski artm\u0131\u015ft\u0131r. Bu h\u00fccreler mikroskop alt\u0131nda anormal olarak g\u00f6r\u00fcl\u00fcrler.
\nDiyet:<\/strong> Hayvansal ya\u011fdan zengin ve et i\u00e7eren g\u0131dalarla beslenmenin baz\u0131 \u00e7al\u0131\u015fmalarda prostat kanser riskini art\u0131rd\u0131\u011f\u0131 g\u00f6sterilmi\u015ftir.
\nBelirtiler: Prostat kanserinin hi\u00e7bir belirtisi olmayaca\u011f\u0131 gibi hastalar; idrar yapma ile ilgili problemle ba\u015fvurabilirler. \u0130drar yapma ile ilgili problemler; idrar yapamama, idrar yapmaya ba\u015flama ya da durdurmada zorlanma, s\u0131k s\u0131k idrara \u00e7\u0131kma, geceleri idrara \u00e7\u0131kma, idrar ak\u0131m\u0131nda zay\u0131flama, kesik kesik zorlanarak idrar yapma, a\u011fr\u0131l\u0131 idrar yapma \u015feklinde olabilir. Bu belirtiler kanser d\u0131\u015f\u0131 nedenlere (prostat b\u00fcy\u00fcmesi, enfeksiyon gibi) de ba\u011fl\u0131 olabilir. Bu belirtiler bulundu\u011funda bir \u00fcroloji uzman\u0131na ba\u015fvurman\u0131z gerekmektedir. Prostat kanserinin kesin tan\u0131s\u0131 biyopsiyle konulur.<\/p>\n

Kanda prostat spesifik antijen (PSA) testi: Hastan\u0131n kan \u00f6rne\u011finde laboratuvarda PSA bak\u0131l\u0131r. PSA prostat kanseri d\u0131\u015f\u0131nda baz\u0131 hastal\u0131klarda da y\u00fckselebilir (prostat\u0131n iltihab\u0131 ya da iyi huylu b\u00fcy\u00fcmesi gibi).<\/p>\n

Kanseri d\u00fc\u015f\u00fcnd\u00fcren herhangi bir belirti oldu\u011funda doktor bunun kansere mi, yoksa ba\u015fka bir nedene mi ait oldu\u011funu anlamaya \u00e7al\u0131\u015f\u0131r. Bunun i\u00e7in detayl\u0131 bir sorgulama ve aile \u00f6yk\u00fcs\u00fc al\u0131nmas\u0131n\u0131n ard\u0131ndan prostat\u0131n parmakla muayenesi, kanda PSA bak\u0131lmas\u0131, idrar tahlili gibi tetkikler yap\u0131l\u0131r.<\/p>\n

15 Eyl\u00fcl D\u00fcnya Prostat Kanseri G\u00fcn\u00fc sebebiyle Kanuni E\u011fitim ve Ara\u015ft\u0131rma Hastanesi ve Fatih Devlet Hastanesi \u00fcroloji poliklinikleri \u00f6n\u00fcnde bulunan stantlarda 09:00-12:00 saatleri aras\u0131nda prostat kanseri ile ilgili bro\u015f\u00fcr da\u011f\u0131t\u0131larak bilgilendirme ve fark\u0131ndal\u0131k \u00e7al\u0131\u015fmas\u0131 yap\u0131lacakt\u0131r.<\/p>\n

Dr. K\u00f6ksal HAMZAO\u011eLU<\/em><\/p>\n

Trabzon Halk Sa\u011fl\u0131\u011f\u0131 M\u00fcd\u00fcr\u00fc<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

\u201cSA\u011eLI\u011eINIZI \u00d6NEMSEY\u0130N, DOKTORUNUZA BA\u015eVURUN\u201d Prostat kanseri erkeklerde en s\u0131k g\u00f6r\u00fclen i\u00e7 organ kanseri ve t\u00fcm d\u00fcnyada en s\u0131k g\u00f6r\u00fclen ikinci kanser t\u00fcr\u00fcd\u00fcr. Yakla\u015f\u0131k olarak her 6 erkekten birinin prostat kanserine yakalanaca\u011f\u0131 ve her 38 erkekten birinin bu hastal\u0131k nedeniyle hayat\u0131n\u0131 kaybedece\u011fi tahmin edilmektedir. T\u00fcm d\u00fcnyada her y\u0131l 899.000 yeni prostat kanseri saptanmakta ve t\u00fcm d\u00fcnyada […]<\/p>\n","protected":false},"author":1,"featured_media":1339,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7,8,11],"tags":[],"class_list":["post-1338","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-etkinlik","category-genel-bilgi","category-saglik"],"_links":{"self":[{"href":"https:\/\/tonyaasm.com\/saglik\/wp-json\/wp\/v2\/posts\/1338","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tonyaasm.com\/saglik\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tonyaasm.com\/saglik\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tonyaasm.com\/saglik\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/tonyaasm.com\/saglik\/wp-json\/wp\/v2\/comments?post=1338"}],"version-history":[{"count":0,"href":"https:\/\/tonyaasm.com\/saglik\/wp-json\/wp\/v2\/posts\/1338\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tonyaasm.com\/saglik\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/tonyaasm.com\/saglik\/wp-json\/wp\/v2\/media?parent=1338"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tonyaasm.com\/saglik\/wp-json\/wp\/v2\/categories?post=1338"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tonyaasm.com\/saglik\/wp-json\/wp\/v2\/tags?post=1338"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}